A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
Public ClinicalTrials.gov record NCT02757768. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With Overactive Bladder (OAB) Symptoms While Taking the Alpha Blocker Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
Study identification
- NCT ID
- NCT02757768
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Astellas Pharma Global Development, Inc.
- Industry
- Enrollment
- 715 participants
Conditions and interventions
Conditions
Interventions
- Mirabegron Drug
- Placebo Drug
- Tamsulosin Hydrochloride Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 12, 2016
- Primary completion
- Aug 13, 2018
- Completion
- Sep 10, 2018
- Last update posted
- Nov 11, 2024
2016 – 2018
United States locations
- U.S. sites
- 32
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site US01009 | Homewood | Alabama | 35209 | — |
| Site US01005 | Huntsville | Alabama | 35749 | — |
| Site US01012 | Anchorage | Alaska | 99503 | — |
| Site US01070 | Hawaiian Gardens | California | 90712 | — |
| Site US01081 | Los Angeles | California | 90035 | — |
| Site US01021 | Murrieta | California | 92562 | — |
| Site US01068 | San Diego | California | 92120 | — |
| Site US01064 | Valley Village | California | 91607 | — |
| Site US01097 | Englewood | Colorado | 80113 | — |
| Site US01026 | Pompano Beach | Florida | 33060 | — |
| Site US01025 | St. Petersburg | Florida | 33710 | — |
| Site US01027 | Wellington | Florida | 33449 | — |
| Site US01034 | West Des Moines | Iowa | 50266 | — |
| Site US01094 | Shreveport | Louisiana | 71106 | — |
| Site US01041 | Baltimore | Maryland | 21287 | — |
| Site US01016 | Boston | Massachusetts | 02131 | — |
| Site US01003 | Watertown | Massachusetts | 02472 | — |
| Site US01060 | Kansas City | Missouri | 64116 | — |
| Site US01067 | Billings | Montana | 59102 | — |
| Site US01061 | Omaha | Nebraska | 68114 | — |
| Site US01029 | Edison | New Jersey | 08837 | — |
| Site US01031 | Albuquerque | New Mexico | 87109 | — |
| Site US01015 | Garden City | New York | 11530 | — |
| Site US01019 | Plainview | New York | 11803 | — |
| Site US01069 | Cary | North Carolina | 25711 | — |
| Site US01079 | Maiden | North Carolina | 28650 | — |
| Site US01072 | Bristol | Tennessee | 37620 | — |
| Site US01042 | Clarksville | Tennessee | 37043 | — |
| Site US01056 | Knoxville | Tennessee | 37909 | — |
| Site US01075 | Knoxville | Tennessee | 37912 | — |
| Site US01078 | Knoxville | Tennessee | 37938 | — |
| Site US01063 | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02757768, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 11, 2024 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02757768 live on ClinicalTrials.gov.